Biotech Meabco expands collaboration with US government

New study results for Meabco's treatment against radiation damage has generated so much attention from collaborative partners in the US government that the latter now intends to expand the deal with the Danish biotech company.

Photo: Klaus Holsting

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles